These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22327870)

  • 21. Adeno-associated virus 2-mediated gene therapy decreases autofluorescent storage material and increases brain mass in a murine model of infantile neuronal ceroid lipofuscinosis.
    Griffey M; Bible E; Vogler C; Levy B; Gupta P; Cooper J; Sands MS
    Neurobiol Dis; 2004 Jul; 16(2):360-9. PubMed ID: 15193292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration.
    Zhang Z; Lee YC; Kim SJ; Choi MS; Tsai PC; Saha A; Wei H; Xu Y; Xiao YJ; Zhang P; Heffer A; Mukherjee AB
    Hum Mol Genet; 2007 Apr; 16(7):837-47. PubMed ID: 17341491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice.
    Gupta P; Soyombo AA; Atashband A; Wisniewski KE; Shelton JM; Richardson JA; Hammer RE; Hofmann SL
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13566-71. PubMed ID: 11717424
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Histochemical localization of palmitoyl protein thioesterase-1 activity.
    Dearborn JT; Ramachandran S; Shyng C; Lu JY; Thornton J; Hofmann SL; Sands MS
    Mol Genet Metab; 2016 Feb; 117(2):210-6. PubMed ID: 26597320
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis.
    Bible E; Gupta P; Hofmann SL; Cooper JD
    Neurobiol Dis; 2004 Jul; 16(2):346-59. PubMed ID: 15193291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Palmitoyl protein thioesterase 1 (PPT1) deficiency causes endocytic defects connected to abnormal saposin processing.
    Ahtiainen L; Luiro K; Kauppi M; Tyynelä J; Kopra O; Jalanko A
    Exp Cell Res; 2006 May; 312(9):1540-53. PubMed ID: 16542649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular correlates of axonal and synaptic pathology in mouse models of Batten disease.
    Kielar C; Wishart TM; Palmer A; Dihanich S; Wong AM; Macauley SL; Chan CH; Sands MS; Pearce DA; Cooper JD; Gillingwater TH
    Hum Mol Genet; 2009 Nov; 18(21):4066-80. PubMed ID: 19640925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synergistic effects of central nervous system-directed gene therapy and bone marrow transplantation in the murine model of infantile neuronal ceroid lipofuscinosis.
    Macauley SL; Roberts MS; Wong AM; McSloy F; Reddy AS; Cooper JD; Sands MS
    Ann Neurol; 2012 Jun; 71(6):797-804. PubMed ID: 22368049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.
    Henderson MX; Wirak GS; Zhang YQ; Dai F; Ginsberg SD; Dolzhanskaya N; Staropoli JF; Nijssen PC; Lam TT; Roth AF; Davis NG; Dawson G; Velinov M; Chandra SS
    Acta Neuropathol; 2016 Apr; 131(4):621-37. PubMed ID: 26659577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The blood-brain barrier is disrupted in a mouse model of infantile neuronal ceroid lipofuscinosis: amelioration by resveratrol.
    Saha A; Sarkar C; Singh SP; Zhang Z; Munasinghe J; Peng S; Chandra G; Kong E; Mukherjee AB
    Hum Mol Genet; 2012 May; 21(10):2233-44. PubMed ID: 22331300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis.
    Griffey MA; Wozniak D; Wong M; Bible E; Johnson K; Rothman SM; Wentz AE; Cooper JD; Sands MS
    Mol Ther; 2006 Mar; 13(3):538-47. PubMed ID: 16364693
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Palmitoyl-protein thioesterase-1 deficiency leads to the activation of caspase-9 and contributes to rapid neurodegeneration in INCL.
    Kim SJ; Zhang Z; Lee YC; Mukherjee AB
    Hum Mol Genet; 2006 May; 15(10):1580-6. PubMed ID: 16571600
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comprehensive functional characterization of murine infantile Batten disease including Parkinson-like behavior and dopaminergic markers.
    Dearborn JT; Harmon SK; Fowler SC; O'Malley KL; Taylor GT; Sands MS; Wozniak DF
    Sci Rep; 2015 Aug; 5():12752. PubMed ID: 26238334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Astrocytosis in infantile neuronal ceroid lipofuscinosis: friend or foe?
    Shyng C; Sands MS
    Biochem Soc Trans; 2014 Oct; 42(5):1282-5. PubMed ID: 25233404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CRISPR/Cas9 mediated generation of an ovine model for infantile neuronal ceroid lipofuscinosis (CLN1 disease).
    Eaton SL; Proudfoot C; Lillico SG; Skehel P; Kline RA; Hamer K; Rzechorzek NM; Clutton E; Gregson R; King T; O'Neill CA; Cooper JD; Thompson G; Whitelaw CB; Wishart TM
    Sci Rep; 2019 Jul; 9(1):9891. PubMed ID: 31289301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response.
    Qiao X; Lu JY; Hofmann SL
    BMC Neurosci; 2007 Nov; 8():95. PubMed ID: 18021406
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteomic Profiling in the Brain of CLN1 Disease Model Reveals Affected Functional Modules.
    Tikka S; Monogioudi E; Gotsopoulos A; Soliymani R; Pezzini F; Scifo E; Uusi-Rauva K; Tyynelä J; Baumann M; Jalanko A; Simonati A; Lalowski M
    Neuromolecular Med; 2016 Mar; 18(1):109-33. PubMed ID: 26707855
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immune cells perturb axons and impair neuronal survival in a mouse model of infantile neuronal ceroid lipofuscinosis.
    Groh J; Kühl TG; Ip CW; Nelvagal HR; Sri S; Duckett S; Mirza M; Langmann T; Cooper JD; Martini R
    Brain; 2013 Apr; 136(Pt 4):1083-101. PubMed ID: 23485853
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neuroprotection of host cells by human central nervous system stem cells in a mouse model of infantile neuronal ceroid lipofuscinosis.
    Tamaki SJ; Jacobs Y; Dohse M; Capela A; Cooper JD; Reitsma M; He D; Tushinski R; Belichenko PV; Salehi A; Mobley W; Gage FH; Huhn S; Tsukamoto AS; Weissman IL; Uchida N
    Cell Stem Cell; 2009 Sep; 5(3):310-9. PubMed ID: 19733542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deficiency of the INCL protein Ppt1 results in changes in ectopic F1-ATP synthase and altered cholesterol metabolism.
    Lyly A; Marjavaara SK; Kyttälä A; Uusi-Rauva K; Luiro K; Kopra O; Martinez LO; Tanhuanpää K; Kalkkinen N; Suomalainen A; Jauhiainen M; Jalanko A
    Hum Mol Genet; 2008 May; 17(10):1406-17. PubMed ID: 18245779
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.